Emcure Pharmaceuticals Limited — Updates, 08-08-2026: General Updates
08-08-2026 | 10:18 am
08-08-2026 | 10:18 am
Emcure Pharmaceuticals received the USFDA's Establishment Inspection Report (EIR) for its Sanand facility. The inspection is closed with a 'Voluntary Action Indicated' (VAI) classification, signaling a positive regulatory outcome for the plant and no action required by the FDA.
No comments yet. Be the first to comment!
